Beryl Drugs informs about compliance certificate

07 Oct 2023 Evaluate
Beryl Drugs has informed that with reference to various conditions stipulated under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other regulation required to be complied by the listed Companies, it enclosed the Compliance Certificate under Regulation 74(51 for the quarter ended 10th September, 2023.

The above information is a part of company’s filings submitted to BSE.

Beryl Drugs Share Price

22.73 1.38 (6.46%)
02-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1714.25
Dr. Reddys Lab 1149.75
Cipla 1452.70
Lupin 2009.40
Zydus Lifesciences 891.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...